View Update Series
View CME info
View all audits
View all discussions
please login to access my bpac
Dont have an account? Sign up here
Forgot your login? Reset password
N.B. The approach of using an ACE inhibitor first-line before trialling an ARB (if the ACE inhibitor is contraindicated or not tolerated) is consistent with 2018 National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Heart Failure guidelines. However, in the 2022 AHA/ACC/HFSA Heart Failure guidelines from the United States ACE inhibitors, ARBs and ARNIs are all now considered first-line options. It is possible that New Zealand guidance may change over time.
It is strongly recommended to review the original resources at your
convenience for full details of recommendations and evidence.
See full articles here: Addressing heart failure in primary care
We have now added the ability to add replies to a comment. Simply click the "Reply to comment" button and complete the form.
Your reply, once signed off, will appear below the comment to which you replied
(if multiple replies to a comment, they will appear in order of submission)
You can still add a fresh comment by scrolling to the bottom of the discussion and clicking the "Add a comment" button.
If someone adds a reply to one of your comments (or replies) you will recieve an email notifying you of this. You can opt out of
(or into if currently out) all comment notification emails by clicking the button below
Please login to make a comment.
Made with by the bpacnz team